ATE222958T1 - Behandlung von glucanen mit enzymen - Google Patents

Behandlung von glucanen mit enzymen

Info

Publication number
ATE222958T1
ATE222958T1 AT95914485T AT95914485T ATE222958T1 AT E222958 T1 ATE222958 T1 AT E222958T1 AT 95914485 T AT95914485 T AT 95914485T AT 95914485 T AT95914485 T AT 95914485T AT E222958 T1 ATE222958 T1 AT E222958T1
Authority
AT
Austria
Prior art keywords
glucan
treatment
yeast
glucans
enzymes
Prior art date
Application number
AT95914485T
Other languages
German (de)
English (en)
Inventor
Rolf Engstad
Finn Kortner
Borre Robertsen
Gunnar Rorstad
Original Assignee
Biotec Pharmacon Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19897060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE222958(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotec Pharmacon Asa filed Critical Biotec Pharmacon Asa
Application granted granted Critical
Publication of ATE222958T1 publication Critical patent/ATE222958T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95914485T 1994-04-29 1995-04-18 Behandlung von glucanen mit enzymen ATE222958T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO941581A NO300692B1 (no) 1994-04-29 1994-04-29 Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
PCT/IB1995/000265 WO1995030022A1 (en) 1994-04-29 1995-04-18 Enzyme treatment of glucans

Publications (1)

Publication Number Publication Date
ATE222958T1 true ATE222958T1 (de) 2002-09-15

Family

ID=19897060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95914485T ATE222958T1 (de) 1994-04-29 1995-04-18 Behandlung von glucanen mit enzymen

Country Status (12)

Country Link
US (3) US7883875B2 (enExample)
EP (1) EP0759089B1 (enExample)
JP (3) JP3992730B2 (enExample)
AT (1) ATE222958T1 (enExample)
AU (1) AU703251B2 (enExample)
CA (1) CA2189010C (enExample)
DE (1) DE69527955T2 (enExample)
DK (1) DK0759089T3 (enExample)
ES (1) ES2182898T3 (enExample)
FI (1) FI114807B (enExample)
NO (1) NO300692B1 (enExample)
WO (1) WO1995030022A1 (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300692B1 (no) * 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
DE19911055A1 (de) 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Verwendung von oberflächenaktiven Gemischen
US8501710B2 (en) * 1999-03-12 2013-08-06 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
DE19911056B9 (de) * 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
DE19911052A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Sonnenschutzmittel
DE19911057C2 (de) * 1999-03-12 2001-01-25 Cognis Deutschland Gmbh Haarkosmetische Zubereitungen
DE19911053B4 (de) 1999-03-12 2004-10-28 Biotec Asa Kosmetische und/oder pharmazeutische Zubereitungen
AU3657100A (en) * 1999-03-12 2000-10-04 Biotec Asa Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
DE19911058B4 (de) 1999-03-12 2004-09-30 Biotec Asa Verwendung von nanoskaligen wasserlöslichen β-(1,3)-Glucanen
US8912165B2 (en) 1999-03-12 2014-12-16 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
DE19917743C2 (de) * 1999-04-20 2003-08-14 Biotec Asa Desodorierende Zubereitungen
DE19917744A1 (de) * 1999-04-20 2000-10-26 Cognis Deutschland Gmbh Dekorative kosmetische Zubereitungen
DE19920557B4 (de) * 1999-05-05 2004-09-09 Biotec Asa Verfahren zur Herstellung von Kollagenfreien kosmetischen Zubereitungen
US20020009463A1 (en) * 2000-02-23 2002-01-24 Jan Raa Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7906492B2 (en) 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
BE1014638A6 (fr) 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
GB0211118D0 (en) 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
US7018986B2 (en) * 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
US20050180964A1 (en) 2003-03-17 2005-08-18 Puntenney Steven B. Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species
JP2004210895A (ja) * 2002-12-27 2004-07-29 Immudyne Japan:Kk 免疫機能を有する可能性β−グルカンの製造方法及び用途
DE602004020117D1 (de) 2004-02-13 2009-04-30 Alpron Co Ltd Verfahren zur herstellung von aus hefe stammendem glucan
US20050220846A1 (en) 2004-04-05 2005-10-06 Puntenney Steven B Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
AU2004218698B2 (en) * 2004-10-08 2011-06-09 Biotec BetaGlucans AS Method
JP4570949B2 (ja) * 2004-12-13 2010-10-27 株式会社アルプロン 酵母由来グルカンの製造方法
EP1948237B8 (en) * 2005-08-10 2012-02-22 Omnigen Research, LLC USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
WO2007084661A2 (en) * 2006-01-17 2007-07-26 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US8142798B2 (en) 2006-04-26 2012-03-27 OmniGen Research, L.L.C. Augmentation of titer for vaccination in animals
EP2066294B9 (en) * 2006-11-06 2013-04-10 Whitehead Institute Immunomodulating compositions and methods of use thereof
US9457047B2 (en) 2006-11-06 2016-10-04 Whitehead Institute Immunomodulating compositions and methods of use thereof
WO2008102151A1 (en) 2007-02-21 2008-08-28 Biotec Pharmacon Asa Medical uses of glucans
MX2009012070A (es) * 2007-05-08 2009-12-08 Biopolymer Engineering Inc Dba Preparacion de glucano soluble en particulas.
FI20070471A0 (fi) * 2007-06-13 2007-06-13 Glykos Finland Oy Ravinnelisäkompositiota
CA2705544A1 (en) * 2007-11-19 2009-05-28 Calanus As Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
EP2224933B1 (en) 2007-11-26 2016-08-03 GlaxoSmithKline Biologicals SA Conjugated beta-1,3-linked glucans
BRPI0900639C1 (pt) * 2009-02-13 2011-12-20 Hebron Farmaceutica Pesquisa Desenvolvimento E Inovacao Tecnologica Ltda composição farmacêutica e uso desta para tratamento e/ou prevenção de doenças do trato respiratório
US9724664B2 (en) 2009-03-27 2017-08-08 Bend Research, Inc. Spray-drying process
JP5242855B2 (ja) * 2010-07-29 2013-07-24 国立大学法人北海道大学 免疫アジュバント
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
US9248584B2 (en) 2010-09-24 2016-02-02 Bend Research, Inc. High-temperature spray drying process and apparatus
GB201020193D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan compositions
GB201020190D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucans
GB201020191D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan gels
WO2012120290A2 (en) 2011-03-04 2012-09-13 Sana Pharma As Cosmetic formulations
FR2981075A1 (fr) 2011-10-11 2013-04-12 Kitozyme Procede de preparation de glucans a partir d'aspergillus niger
MD4329C1 (ro) * 2013-10-30 2015-09-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Procedeu de cultivare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20
EP3110437B1 (en) 2014-02-12 2017-11-29 Omnigen Research, LLC Composition and method for promoting reduction of heat stress in animals
WO2016067132A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix
WO2017044832A1 (en) 2015-09-09 2017-03-16 Omnigen Research, Llc A composition and/or combination for aquaculture
JPWO2022045371A1 (enExample) * 2020-08-31 2022-03-03

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2764463A (en) 1953-05-26 1956-09-25 Underwood Corp Magnetic recording system
US3954979A (en) * 1972-11-24 1976-05-04 Ceres Products Company, Inc. Process for preparing stabilized yeast and compositions and tableting composition and method
JPS5432076B2 (enExample) 1973-09-14 1979-10-11
JPS54138115A (en) * 1978-04-17 1979-10-26 Kirin Brewery Antiicancer agent
GB2076418A (en) 1980-05-22 1981-12-02 Sankyo Co Hydrolyzed polysaccharide
JPS6019619B2 (ja) 1980-09-19 1985-05-17 株式会社日立製作所 Ｘ線管用回転陽極
SE456911B (sv) * 1983-12-19 1988-11-14 Olle Larm Vattenloeslig, aminerad beta-1,3-bunden d-glukan och makrofagstimulerande komposition innehaallande densamma
JPS60196195A (ja) 1984-03-21 1985-10-04 Dainippon Seito Kk イ−ストグルカンの製造法
US5082936A (en) * 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US4810646A (en) * 1984-11-28 1989-03-07 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US5028703A (en) * 1988-03-11 1991-07-02 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5057503A (en) * 1989-01-23 1991-10-15 The Brigham And Women's Hospital Derivativized polysaccharides with biologic activity, method of their isolation, and uses therefor
CA1330303C (en) * 1989-02-20 1994-06-21 Libor Henry Nikl Composition and process to enhance the efficacy of a fish vaccine
WO1991003248A2 (en) * 1989-09-08 1991-03-21 Alpha Beta Technology, Inc. Method for immune system activation
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
WO1991003495A1 (en) * 1989-09-08 1991-03-21 Alpha Beta Technology, Inc. Method for producing soluble glucans
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US6020324A (en) * 1989-10-20 2000-02-01 The Collaborative Group, Ltd. Glucan dietary additives
CA2040374C (en) * 1990-07-06 1998-06-16 Gunnar Rorstad Process for enhancing the resistance of aquatic animals to disease
NO300692B1 (no) 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan

Also Published As

Publication number Publication date
JP3992730B2 (ja) 2007-10-17
NO941581D0 (enExample) 1994-04-29
JP2007228974A (ja) 2007-09-13
US20080124349A1 (en) 2008-05-29
US8252295B2 (en) 2012-08-28
FI964339L (fi) 1996-10-28
ES2182898T3 (es) 2003-03-16
CA2189010A1 (en) 1995-11-09
AU2146495A (en) 1995-11-29
US7883875B2 (en) 2011-02-08
FI114807B (fi) 2004-12-31
NO300692B1 (no) 1997-07-07
JPH09512708A (ja) 1997-12-22
EP0759089A1 (en) 1997-02-26
JP2009051863A (ja) 2009-03-12
AU703251B2 (en) 1999-03-25
CA2189010C (en) 2010-07-13
EP0759089B1 (en) 2002-08-28
US20110104208A1 (en) 2011-05-05
US8142785B2 (en) 2012-03-27
FI964339A0 (fi) 1996-10-28
DE69527955D1 (de) 2002-10-02
DE69527955T2 (de) 2003-04-10
NO941581L (no) 1995-10-30
WO1995030022A1 (en) 1995-11-09
US20050255565A1 (en) 2005-11-17
DK0759089T3 (da) 2003-01-06

Similar Documents

Publication Publication Date Title
ATE222958T1 (de) Behandlung von glucanen mit enzymen
AU6229686A (en) Soluble phosphorylated glucan
MX9101622A (es) Procesamiento de residuo de levaduras y el producto resultante
SE8004386L (sv) Etanolframstellning
ID25515A (id) Bahan tumbuhan terfermentasi penghambat rambatan penyakit (metastasis) dan stimulator kekebalan
ES8606906A1 (es) Procedimiento para preparar productos que contienen oligosacaridos a partir de biomasa triturada.
DE69431162D1 (en) Fenbendazolformulierungen
GB1474313A (en) Process for preparing a protein concentrate from a microbial cell mass and the protein concentrate thus obtained
Ortega et al. Effect of prolactin on the in vitro phagocytic capacity of macrophages
FR2786394B1 (fr) Extrait de tourteau de graine de noix, composition cosmetique comprenant ledit extrait et applications
JPS5381691A (en) Preparation of l-serine
JPS6442412A (en) Skin-beautifying cosmetic
ES8602113A1 (es) Procedimiento para preparar a-cetoacidos, sus esteres y eteres
EP0083931A3 (en) New bestatin-related compounds as immunopotentiator
SI1196182T1 (sl) Postopek za povečanje zmogljivosti proizvodnje pri živali
EP1237093A3 (en) Methods and apparatus for associating character codes with optimized character codes
KR920012448A (ko) 홍국균의 배양방법 및 홍국색소 추출방법
EP0763852A3 (de) Gehäuse für ein Leistungs-Halbleitermodul
IE800772L (en) Immunostimulant substance
RU94025418A (ru) Витаминное средство
Rusinov Linear selection of highly productive strains of Penicillium chrysogenum
KR900016458A (ko) 신규한 균주 사카로 미세스, 세례비제(Saccharomyces cerevisiae) JY10035 및 이것을 이용한 에탄올 제조방법
KR880013440A (ko) 미생물을 이용한 발효축사
KR970068883A (ko) 다시마 속 YCH-37(Dicyma sp. YCH-37)KFCC-10851 균주가 생산하는 효모세포벽 용해효소를 이용한 효모엑기스의 제조방법
Kupriyanova-Ashina et al. Effects of RNase from Bacillus intermedius on the growth of Saccharomyces cerevisiae

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0759089

Country of ref document: EP